Skip Navigation
Skip to contents

Journal of Microbiology : Journal of Microbiology

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Browse Articles > Author index
Search
Hyoung Jin Kim 4 Articles
IgG and IgM responses to human papillomavirus L1 virus-like particle as a function of dosing schedule and vaccine formulation
Min-Hye Park , Ji Won You , Hyoung Jin Kim , Hong-Jin Kim
J. Microbiol. 2019;57(9):821-827.   Published online August 27, 2019
DOI: https://doi.org/10.1007/s12275-019-9308-z
  • 919 View
  • 0 Download
  • 4 Web of Science
  • 4 Crossref
AbstractAbstract PDF
Most commercialized virus-like particle (VLP) vaccines use aluminum salt as adjuvant, even though VLPs provoke adequate antibody responses without adjuvant. We do not have detailed knowledge of how adjuvant affects the profile of anti- VLP antibodies. Meanwhile, there is evidence that differences between vaccination protocols influence the glycosylation of antibodies, which may alter their effector functions. In the present study a murine model was used to investigate the effects of dosing schedule and adjuvant on the antibody profiles and glycosylation levels of antigen-specific antibody responses to human papillomavirus type 16 L1 (HPV16 L1) VLPs. Mice received subcutaneously 2,000 ng of antigen divided into 4 or 7 doses. The HPV16 L1 VLPs elicited > 4 log10 anti-HPV16 L1 IgG titers without adjuvant, and aluminum hydroxide as adjuvant increased IgG titers 1.3- to 4-fold and reduced the anti-HPV16 L1 IgG2a / anti-HPV16 L1 IgG1 ratio value (use of aluminum hydroxide reduced the ratio of the IgG2a). Immunization with HPV16 L1 VLPs in combination with Freund’s adjuvant enhanced IgG titers 5- to 12- fold. Seven-dose immunization markedly increased anti- HPV16 L1 IgM titers compared to four-dose immunization, as well as increasing the proportion of glycosylated antibodies. Our results suggest that antibody glycosylation can be controlled immunologically, and IgG and IgM profiles and glycosylation profiles of the vaccine-induced antibodies can be used as indicators reflecting the vaccine characteristics. These
results
indicate that the HPV16 L1 VLP dosing schedule can affect the quality of antigen-specific antibody responses. We suggest that dosing schedules should be noted in vaccination protocols for VLP-based vaccines.

Citations

Citations to this article as recorded by  
  • Human papillomavirus vaccines: organisation and experience of preclinical studies
    A. S. Korovkin, T. N. Nikitina, T. Yu. Kozlova, D. V. Gorenkov, A. R. Volgin
    Biological Products. Prevention, Diagnosis, Treatment.2024; 24(3): 243.     CrossRef
  • Chimeric Hepatitis B core virus-like particles harboring SARS-CoV2 epitope elicit a humoral immune response in mice
    Sima Sazegari, Malihe Akbarzadeh Niaki, Alireza Afsharifar, Ali Niazi, Abdollah Derakhshandeh, Maryam Moradi Vahdat, Farshad Hemmati, Mohammad Hadi Eskandari
    Microbial Cell Factories.2023;[Epub]     CrossRef
  • Anti-JMH alloantibody in inherited JMH-negative patients leads to immunogenic destruction of JMH-positive RBCs
    Zhaohu Yuan, Yaming Wei, Xiaojie Chen, Shufei He, Kui Cai, Minglu Zhong, Huiying Huang, Xinxin Tong, Zhen Liu, Xuexin Yang
    Clinical and Experimental Immunology.2021; 205(2): 182.     CrossRef
  • Prevalence of antibodies against a cyclic peptide mimicking the FG loop of the human papillomavirus type 16 capsid among Tunisian women
    Elham Hassen, Devendra Bansal, Randa Ghdira, Anouar Chaieb, Hedi Khairi, Abdelfattah Zakhama, Sami Remadi, Johan Hoebeke, Ali A. Sultan, Lotfi Chouchane
    Journal of Translational Medicine.2020;[Epub]     CrossRef
The effect of dietary bovine colostrum on respiratory syncytial virus infection and immune responses following the infection in the mouse
Mei Ling Xu , Hyoung Jin Kim , Ga Ram Wi , Hong-Jin Kim
J. Microbiol. 2015;53(9):661-666.   Published online August 27, 2015
DOI: https://doi.org/10.1007/s12275-015-5353-4
  • 1,348 View
  • 2 Download
  • 20 Crossref
AbstractAbstract PDF
Human respiratory syncytial virus (hRSV) is the most common cause of respiratory tract infection among young children because of immature T cell immunity of them against hRSV. CD8 T cells play a pivotal role in clearing hRSV and preventing subsequent infection. We examined the effects of dietary bovine colostrum on virus infection and CD8 T cell responses following hRSV infection in the mouse model. Mice received bovine colostrum for 14 days prior to hRSV challenge, and lung indexes (severity of symptom) and lung virus titers were analyzed. In addition, the activation of CD8 T cells in the bronchoalveolar lavage fluids (BALFs) of mice receiving bovine colostrum were compared with those in the BALFs of mice receiving phosphate-buffered saline (PBS) or ribavirin, post virus challenge. The severity of infection and lung virus titers were reduced in the mice receiving bovine colostrum, compared to those receiving PBS. Moreover CD8 T cell responses were selectively enhanced in the former. Our results suggest that dietary bovine colostrum exerts the effects to inhibit hRSV and ameliorate the symptom by hRSV infection, and enhances the CD8 T cell response during the hRSV infection.

Citations

Citations to this article as recorded by  
  • Bovine Colostrum: Unveiling its Potent Health Benefits and Emerging Trends in Optimizing Well-being
    Archna Singh, Avijit Mazumder, Saumya Das, Anmol Kanda, Vishnu Prabhakar, Rashmi Mishra, MVNL Chaitanya
    The Natural Products Journal.2025;[Epub]     CrossRef
  • Improved physical disability and nutritional status by bovine colostrum supplementation in adults with traumatic peri-trochanteric femoral fracture: A randomized, controlled, clinical trial
    Faezeh Gouhari, Reza Zandi, Amir Mehrvar, Shahin Talebi, Zahra Vahdat Shariatpanahi
    Injury.2024; 55(3): 111253.     CrossRef
  • Systemic immune markers and infection risk in preterm infants fed human milk fortified with bovine colostrum or conventional fortifier, a secondary analysis of the FortiColos trial
    Ole Bæk, Tik Muk, Lise Aunsholt, Gitte Zachariasen, Per Torp Sangild, Duc Ninh Nguyen
    Infection.2024; 52(6): 2315.     CrossRef
  • Role of bovine colostrum against various diseases
    Yalçın Mert Yalçıntaş, Hatice Duman, João Miguel Rocha, Elena Bartkiene, Sercan Karav, Fatih Ozogul
    Food Bioscience.2024; 61: 104818.     CrossRef
  • Colostrum supplement, immune variables and hospital-acquired infection in acute respiratory failure: A double-blind, randomized, placebo-controlled study
    Elham Roohelhami, Seyed Hossein Ardehali, Elham Makiabadi, Zahra Vahdat Shariatpanahi
    Journal of Functional Foods.2023; 111: 105909.     CrossRef
  • Review: Colostrum as an Emerging food: Nutraceutical Properties and Food Supplement
    Carlotta Ceniti, Nicola Costanzo, Valeria Maria Morittu, Bruno Tilocca, Paola Roncada, Domenico Britti
    Food Reviews International.2023; 39(7): 4636.     CrossRef
  • Bovine colostrum and its potential contributions for treatment and prevention of COVID-19
    Hatice Duman, Sercan Karav
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • Hyper-Immune Bovine Milk as an Immunological and Nutritional Supplement for COVID-19
    Hassan Nili, Majid Bouzari, Hamid Reza Attaran, Nader Ghalegolab, Mohammad Rabani, Ahmad Mahmoudian
    Frontiers in Nutrition.2022;[Epub]     CrossRef
  • A REVIEW ON LACTOFERRIN PRINCIPLE CONSTITUENT OF BOVINE COLOSTRUM: IN COVID19
    AISHWARYA S. PATIL, RANI PURI, B. S. WAKURE
    International Journal of Current Pharmaceutical Research.2022; : 1.     CrossRef
  • Direct Binding of Bovine IgG-Containing Immune Complexes to Human Monocytes and Their Putative Role in Innate Immune Training
    Mojtaba Porbahaie, Huub F. J. Savelkoul, Cornelis A. M. de Haan, Malgorzata Teodorowicz, R. J. Joost van Neerven
    Nutrients.2022; 14(21): 4452.     CrossRef
  • Promising traditional Indian medicinal plants for the management of novel Coronavirus disease: A systematic review
    Rahul Soloman Singh, Ashutosh Singh, Harpinder Kaur, Gitika Batra, Phulen Sarma, Hardeep Kaur, Anusuya Bhattacharyya, Amit Raj Sharma, Subodh Kumar, Sujata Upadhyay, Vinod Tiwari, Pramod Avti, Ajay Prakash, Bikash Medhi
    Phytotherapy Research.2021; 35(8): 4456.     CrossRef
  • Bovine colostrum: benefits for the human respiratory system and potential contributions for clinical management of COVID-19
    Alyne Batista da Silva Galdino, Adriano Henrique do Nascimento Rangel, Harpal Singh Buttar, Manuela Sales Lima Nascimento, Elaine Cristina Gavioli, Riva de Paula Oliveira, Danielle Cavalcanti Sales, Stela Antas Urbano, Katya Anaya
    Food and Agricultural Immunology.2021; 32(1): 143.     CrossRef
  • The Impact of Milk and Its Components on Epigenetic Programming of Immune Function in Early Life and Beyond: Implications for Allergy and Asthma
    Betty C. A. M. van Esch, Mojtaba Porbahaie, Suzanne Abbring, Johan Garssen, Daniel P. Potaczek, Huub F. J. Savelkoul, R. J. Joost van Neerven
    Frontiers in Immunology.2020;[Epub]     CrossRef
  • Can Drinking Microfiltered Raw Immune Milk From Cows Immunized Against SARS-CoV-2 Provide Short-Term Protection Against COVID-19?
    Samir Jawhara
    Frontiers in Immunology.2020;[Epub]     CrossRef
  • Bovine IgG Prevents Experimental Infection With RSV and Facilitates Human T Cell Responses to RSV
    Maaike Nederend, Arthur H. van Stigt, J. H. Marco Jansen, Shamir R. Jacobino, Sylvia Brugman, Cornelis A. M. de Haan, Louis J. Bont, R. J. Joost van Neerven, Jeanette H. W. Leusen
    Frontiers in Immunology.2020;[Epub]     CrossRef
  • Therapeutic Applications of Human and Bovine Colostrum in the Treatment of Gastrointestinal Diseases and Distinctive Cancer Types: The Current Evidence
    Siddhi Bagwe-Parab, Pratik Yadav, Ginpreet Kaur, Hardeep Singh Tuli, Harpal Singh Buttar
    Frontiers in Pharmacology.2020;[Epub]     CrossRef
  • Enriched bovine IgG fraction prevents infections with Enterohaemorrhagic Escherichia coli O157:H7, Salmonella enterica serovar Enteritidis, and Mycobacterium avium
    Keiji Funatogawa, Tatsuya Tada, Kyoko Kuwahara‐Arai, Teruo Kirikae, Masao Takahashi
    Food Science & Nutrition.2019; 7(8): 2726.     CrossRef
  • Melatonin, a toll‐like receptor inhibitor: Current status and future perspectives
    Omid Reza Tamtaji, Moein Mobini, Russel J. Reiter, Abolfazl Azami, Mohammad Saeed Gholami, Zatollah Asemi
    Journal of Cellular Physiology.2019; 234(6): 7788.     CrossRef
  • Effects of Bovine Immunoglobulins on Immune Function, Allergy, and Infection
    Laurien H. Ulfman, Jeanette H. W. Leusen, Huub F. J. Savelkoul, John O. Warner, R. J. Joost van Neerven
    Frontiers in Nutrition.2018;[Epub]     CrossRef
  • Ameliorating Effect of Dietary Xylitol on Human Respiratory Syncytial Virus (hRSV) Infection
    Mei Ling Xu, Ga Ram Wi, Hyoung Jin Kim, Hong-Jin Kim
    Biological & Pharmaceutical Bulletin.2016; 39(4): 540.     CrossRef
The Effect of Dietary Intake of the Acidic Protein Fraction of Bovine Colostrum on Influenza A (H1N1) Virus Infection
Mei Ling Xu , Hyoung Jin Kim , Don Yong Chang , Hong-Jin Kim
J. Microbiol. 2013;51(3):389-393.   Published online April 26, 2013
DOI: https://doi.org/10.1007/s12275-013-2683-y
  • 672 View
  • 0 Download
  • 6 Crossref
AbstractAbstract PDF
Acidic protein levels in the milk decrease markedly as lactation progresses, suggesting that it is an important part of the colostrum. However, little attention has been paid to their biological function. In this study, we isolated the acidic protein fraction of bovine colostrum (AFC, isoelectric point <5) by anion-exchange chromatography, and investigated the effect of its dietary intake on influenza A (H1N1) virus infection. 100% of mice infected with 1 LD50 of the virus survived when administered AFC for 14 days prior to infection, compared with 33% survival when administered phosphate buffered saline (PBS). Moreover, consumption of AFC reduced the weight loss associated with infection. We propose that dietary intake of AFC has a prophylactic effect on influenza A virus infection.

Citations

Citations to this article as recorded by  
  • The Toxic Effects of Low Molecular Weight Components of Cow Colostrums: The Short-Term and Long-Term Effects
    A.I. Bozhkov, E.G. Ivanov, N.I. Kurguzova, Muhammad M.A. Alsardia, R.A. Akzhigitov, S.Ya. Baranikova, V.I. Potapova, A.S. Chuprikova
    Journal of Nutritional Therapeutics.2021; 6(4): 84.     CrossRef
  • Bovine colostrum: benefits for the human respiratory system and potential contributions for clinical management of COVID-19
    Alyne Batista da Silva Galdino, Adriano Henrique do Nascimento Rangel, Harpal Singh Buttar, Manuela Sales Lima Nascimento, Elaine Cristina Gavioli, Riva de Paula Oliveira, Danielle Cavalcanti Sales, Stela Antas Urbano, Katya Anaya
    Food and Agricultural Immunology.2021; 32(1): 143.     CrossRef
  • Influenza A in Bovine Species: A Narrative Literature Review
    Chithra C. Sreenivasan, Milton Thomas, Radhey S. Kaushik, Dan Wang, Feng Li
    Viruses.2019; 11(6): 561.     CrossRef
  • Effective Components of Bovine Colostrum and Its Applications
    Sang-Ah Seo, Hye-Ryoung Seo, Young-Tae Heo
    Journal of Animal Reproduction and Biotechnology.2018; 33(3): 159.     CrossRef
  • The effect of dietary bovine colostrum on respiratory syncytial virus infection and immune responses following the infection in the mouse
    Mei Ling Xu, Hyoung Jin Kim, Ga Ram Wi, Hong-Jin Kim
    Journal of Microbiology.2015; 53(9): 661.     CrossRef
  • Effect of dietary bovine colostrum on the responses of immune cells to stimulation with bacterial lipopolysaccharide
    Mei Ling Xu, Hyoung Jin Kim, Hong-Jin Kim
    Archives of Pharmacal Research.2014; 37(4): 494.     CrossRef
The Production and Immunogenicity of Human Papillomavirus Type 58 Virus-like Particles Produced in Saccharomyces cerevisiae
Hye-Lim Kwag , Hyoung Jin Kim , Don Yong Chang , Hong-Jin Kim
J. Microbiol. 2012;50(5):813-820.   Published online November 4, 2012
DOI: https://doi.org/10.1007/s12275-012-2292-1
  • 824 View
  • 0 Download
  • 15 Crossref
AbstractAbstract PDF
Human papillomavirus (HPV) is the cause of most cases of cervical cancer. HPV type 58 (HPV58) is the second most frequent cause of cervical cancer and high-grade squamous intraepithelial lesions (HSIL) in Asia and South / Central America, respectively. However, there is no vaccine against HPV58, although there are commercially available vaccines against HPV16 and 18. In this study, we produced HPV58 L1 protein from Saccharomyces cerevisiae, and investigated its immunogenicity. We first determined the optimum period of culture for obtaining HPV58 L1. We found that a considerable portion of the HPV58 L1 resulting from 48 h culture cannot be recovered by purification, while the HPV58 L1 resulting from 144 h culture is recovered efficiently: the yield of HPV58 L1 finally recovered from 144 h culture was 2.3 times higher than that from 48 h culture, although the production level of L1 protein from 144 h culture was lower than that from 48 h culture. These results indicate that the proportion of functional L1 protein from 144 h-cultured cells is significantly higher than that of 48 h-cultured cells. The HPV58 L1 purified from the 144 h culture was correctly assembled into structures similar to naturally occurring HPV virions. Immunization with the HPV58 L1 efficiently elicited anti-HPV58 neutralizing antibodies and antigen-specific CD4+ and CD8+ T cell proliferations, without the need for adjuvant. Our findings provide a convenient method for obtaining substantial amounts of highly immunogenic HPV58 L1 from S. cerevisiae.

Citations

Citations to this article as recorded by  
  • Model microorganisms: From cornerstones of modern discovery to big data-driven platforms
    Man Li, Zhongjian Song, Juan Du, Yuwei Wu, Moutong Chen, Lianying Ma, Qingping Wu
    Model Organisms Research.2026; 1(1): 100009.     CrossRef
  • Expression, purification, and immunogenicity study of human papillomavirus type 52 virus-like particles produced in Hansenula polymorpha
    Sheila Chairunnisa, Apon Zaenal Mustopa, Budiman Bela, Rosyida Khusniatul Arifah, Rifqiyah Nur Umami, Moh Egy Rahman Firdaus, Nurlaili Ekawati, Herman Irawan, Shasmita Irawan, Maritsa Nurfatwa, Ai Hertati, Sri Swasthikawati, Ela Novianti, Arizah Kusumawat
    Biologicals.2025; 90: 101831.     CrossRef
  • Yeast and Virus-like Particles: A Perfect or Imperfect Couple?
    Sara Brachelente, Alvaro Galli, Tiziana Cervelli
    Applied Microbiology.2023; 3(3): 805.     CrossRef
  • Yeast-Based Virus-like Particles as an Emerging Platform for Vaccine Development and Delivery
    Vartika Srivastava, Kripa N. Nand, Aijaz Ahmad, Ravinder Kumar
    Vaccines.2023; 11(2): 479.     CrossRef
  • How far have we explored fungi to fight cancer?
    Chee Wun How, Yong Sze Ong, Sze Shin Low, Ashok Pandey, Pau Loke Show, Jhi Biau Foo
    Seminars in Cancer Biology.2022; 86: 976.     CrossRef
  • Yeast-based vaccines: New perspective in vaccine development and application
    Ravinder Kumar, Piyush Kumar
    FEMS Yeast Research.2019;[Epub]     CrossRef
  • Advances in Designing and Developing Vaccines, Drugs and Therapeutic Approaches to Counter Human Papilloma Virus
    Maryam Dadar, Sandip Chakraborty, Kuldeep Dhama, Minakshi Prasad, Rekha Khandia, Sameer Hassan, Ashok Munjal, Ruchi Tiwari, Kumaragurubaran Karthik, Deepak Kumar, Hafiz M. N. Iqbal, Wanpen Chaicumpa
    Frontiers in Immunology.2018;[Epub]     CrossRef
  • The codon-optimized capsid gene of duck circovirus can be highly expressed in yeast and self-assemble into virus-like particles
    Cui YANG, Yu XU, Ren-yong JIA, Si-yang LIU, Ming-shu WANG, De-kang ZHU, Shun CHEN, Ma-feng LIU, Xin-xin ZHAO, Kun-feng SUN, Bo JING, Zhong-qiong YIN, An-chun CHENG
    Journal of Integrative Agriculture.2017; 16(7): 1601.     CrossRef
  • A novel trivalent HPV 16/18/58 vaccine with anti-HPV 16 and 18 neutralizing antibody responses comparable to those induced by the Gardasil quadrivalent vaccine in rhesus macaque model
    Fei Yin, Yajun Wang, Na Chen, Dunquan Jiang, Yefeng Qiu, Yan Wang, Mei Yan, Jianping Chen, Haijiang Zhang, Yongjiang Liu
    Papillomavirus Research.2017; 3: 85.     CrossRef
  • EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge
    Xiaowen Wang, Xiangqian Xiao, Miao Zhao, Wei Liu, Lin Pang, Xin Sun, Shan Cen, Burton B. Yang, Yuming Huang, Wang Sheng, Yi Zeng
    BMC Research Notes.2016;[Epub]     CrossRef
  • Therapeutic potential of an AcHERV-HPV L1 DNA vaccine
    Hee-Jung Lee, Jong Kwang Yoon, Yoonki Heo, Hansam Cho, Yeondong Cho, Yongdae Gwon, Kang Chang Kim, Jiwon Choi, Jae Sung Lee, Yu-Kyoung Oh, Young Bong Kim
    Journal of Microbiology.2015; 53(6): 415.     CrossRef
  • Immunogenicity of a Trivalent Human Papillomavirus L1 DNA-Encapsidated, Non-Replicable Baculovirus Nanovaccine
    Hansam Cho, Hee-Jung Lee, Yoon-Ki Heo, Yeondong Cho, Yong-Dae Gwon, Mi-Gyeong Kim, Ki Hoon Park, Yu-Kyoung Oh, Young Bong Kim, Shibo Jiang
    PLoS ONE.2014; 9(4): e95961.     CrossRef
  • The Concentration of Carbon Source in the Medium Affects the Quality of Virus-Like Particles of Human Papillomavirus Type 16 Produced in Saccharomyces cerevisiae
    Hyoung Jin Kim, Yingji Jin, Hong-Jin Kim, Paulo Lee Ho
    PLoS ONE.2014; 9(4): e94467.     CrossRef
  • Panorámica de los receptores celulares del virus del papiloma humano y su repercusión en la purificación de partículas semejantes a virus
    J.F. Beltrán-Lissabet
    Vacunas.2014; 15(1-2): 29.     CrossRef
  • Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice
    Hao-Yang Li, Jian-Feng Han, Cheng-Feng Qin, Rong Chen
    Vaccine.2013; 31(32): 3281.     CrossRef

Journal of Microbiology : Journal of Microbiology
TOP